Oncogene pathway activation in mammary tumors dictates FDG-PET uptake - Wikidata - awgldk - TriplyDB

Oncogene pathway activation in mammary tumors dictates FDG-PET uptake

Oncogene pathway activation in mammary tumors dictates FDG-PET uptake

http://www.wikidata.org/entity/Q35125252

about

Glucose is a key driver for GLUT1-mediated nanoparticles internalization in breast cancer cells Mechanisms underlying 18F-fluorodeoxyglucose accumulation in colorectal cancer Warburg effect, hexokinase-II, and radioresistance of laryngeal carcinoma Do clinical, histological or immunohistochemical primary tumour characteristics translate into different (18)F-FDG PET/CT volumetric and heterogeneity features in stage II/III breast cancer?Carnitine palmitoyltransferase 1A functions to repress FoxO transcription factors to allow cell cycle progression in ovarian cancer.Reporter nanoparticle that monitors its anticancer efficacy in real time.(18)F-FDG PET/CT for Monitoring the Response of Breast Cancer to miR-143-Based Therapeutics by Targeting Tumor Glycolysis 18F-FDG super bone marrow uptake: A highly potent indicator for the malignant infiltration.Prognostic significance and function of the vacuolar H+-ATPase subunit V1E1 in esophageal squamous cell carcinoma.A Retrospective 30 Years After Discovery of the Enhanced Permeability and Retention Effect of Solid Tumors: Next-Generation Chemotherapeutics and Photodynamic Therapy--Problems, Solutions, and Prospects.¹⁸F-FDG PET/CT in the early prediction of pathological response in aggressive subtypes of breast cancer: review of the literature and recommendations for use in clinical trials.Imaging of Tumor Metabolism Using Positron Emission Tomography (PET).Altered oxidative stress and carbohydrate metabolism in canine mammary tumors.Low expression of hexokinase-2 is associated with false-negative FDG-positron emission tomography in multiple myeloma.PHLPP regulates hexokinase 2-dependent glucose metabolism in colon cancer cells.Tissue and imaging biomarkers for hypoxia predict poor outcome in endometrial cancer.Sodium glucose cotransporter 2 inhibitor canagliflozin attenuates liver cancer cell growth and angiogenic activity by inhibiting glucose uptake.Combined PET/MRI: Global Warming-Summary Report of the 6th International Workshop on PET/MRI, March 27-29, 2017, Tübingen, Germany.A novel genomic signature predicting FDG uptake in diverse metastatic tumors.Foxo-dependent Par-4 Upregulation Prevents Long-term Survival of Residual Cells Following PI3K-Akt Inhibition.The carnitine system and cancer metabolic plasticity.

P2860

Q27345982-A48C65EB-B8B7-4DA2-B3FC-032AAE224933 Q28067736-20691AB8-14D7-4CAF-BA3C-2390F2D03537 Q28072714-CBDE22E1-6293-45E0-B534-EA9E58A7E2BD Q33576007-44789445-ABFE-4DB9-8D42-D2F8237D1EF5 Q36782280-1040B1E2-F832-4D31-98D1-D5449149743C Q36821565-853E435F-D34F-4781-B4D1-E5B9D7DF4DD5 Q37256225-2AF54D72-9EFA-4C30-9338-3A4B696304BD Q37552097-EC1E979B-381B-4BBE-965B-5094C63B1557 Q37580227-4D69B75F-7734-4A98-9985-FF17777E2721 Q38559666-EFB9E238-B577-4502-A6CC-A9CF2CBF0A95 Q38693888-9078F932-2C07-4EB6-A4D1-A41E6D8621D0 Q38936273-CEC814B5-A38C-4548-BF30-5DD0A955A3C8 Q39015978-BC5AE3F5-59F5-4EEA-8542-53A15354DB7F Q40232283-80E85019-5FDF-4779-AC03-CC4E78A6B3FF Q41876633-EDE0FCA8-6F06-4A82-A42C-EF7FDF564EEA Q42317488-2D2AF54C-C237-43C6-B3D7-CEE089D1B26F Q47330547-34298C10-E6C0-461D-ACBC-3FC71E627E2A Q47608030-87EEA926-ABCD-4687-8700-BA585837ACC9 Q49207442-038FA6F3-534C-472A-8116-D22D21E4A9C7 Q50059072-4048AB84-F8AC-4A24-93F2-C7F293E3459A Q51769132-C2FF0289-4B37-4BC5-BC26-EA92F2E01C60

P2860

Oncogene pathway activation in mammary tumors dictates FDG-PET uptake

http://www.wikidata.org/entity/Q35125252

description

2014 nî lūn-bûn

@nan

2014 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Oncogene pathway activation in mammary tumors dictates FDG-PET uptake

@ast

Oncogene pathway activation in mammary tumors dictates FDG-PET uptake

@en

type

label

Oncogene pathway activation in mammary tumors dictates FDG-PET uptake

@ast

Oncogene pathway activation in mammary tumors dictates FDG-PET uptake

@en

prefLabel

Oncogene pathway activation in mammary tumors dictates FDG-PET uptake

@ast

Oncogene pathway activation in mammary tumors dictates FDG-PET uptake

@en

P1433

Q35125252-D7AA73C1-E990-46B5-9064-E14E6E53D822

P1476

Q35125252-F593FED9-7087-403C-97AD-388EF9DDC7AF

P2093

Q35125252-1797699C-791D-475E-A6BF-86E975657D5B

Q35125252-20FEB33E-073D-4637-9295-0BD73DAD522E

Q35125252-2D4EF262-7A15-41A4-989E-04E12D3C7D6D

Q35125252-5E84879F-E7F2-4B17-A839-2A5F8CD98FBA

Q35125252-65441CC1-EBA9-4BD0-B05C-149C1EAA0691

Q35125252-88D2CEE1-5ACD-4341-8296-042C86519828

Q35125252-8B4B717A-F36B-4D42-95D8-255E2806877E

Q35125252-BD6885F1-39E5-490F-AE83-5D3CCA7B867A

P2860

Q35125252-0A3C5E64-376C-42C5-A999-650D5460D84A

Q35125252-1B37F889-EB32-413E-8DE4-C32F197AFB0F

Q35125252-1BE5772A-AD1E-449D-B2C0-B95EB93F038E

Q35125252-23AE3B1F-575F-4B6E-9F71-C2B0C1852A01

Q35125252-30031E0B-B57E-4AC0-A412-27AB3EDDF344

Q35125252-30A3D1D0-FF39-4D00-B3B0-27631B4196E8

Q35125252-3142DE8C-BCE1-4039-B945-F9DE3173E7E4

Q35125252-3549BAD2-EDE8-438B-BBD3-00674D670BED

Q35125252-441F5C09-0C4A-4D6E-90C0-835E5CCB79A5

Q35125252-478B92EA-E806-474B-A958-B7A57725840E

P304

Q35125252-4624C8F8-1DC3-4B50-941E-8073D6CED9A2

P31

Q35125252-441253EE-B52C-42D4-B006-A897FA682A9A

P356

Q35125252-0553ABC2-4FC1-4F2F-9162-71B66CCA1ABC

P407

Q35125252-FAD02859-B245-4E12-943C-6312DA456288

P433

Q35125252-036A7C71-2EC6-4678-A52A-E98C8BA828F8

P478

Q35125252-7EC3B82E-79F0-401D-8C01-3B99CF52AE28

P577

Q35125252-E2466202-1C8B-4E35-A854-DAD97957DEDF

P698

Q35125252-3EF83D30-DBF5-46C0-8F9B-1FDAAA432940

P932

Q35125252-909BF51F-524C-40C7-9C5B-FC815AA7156A

P356

0008-5472.CAN-14-1235

P1433

Cancer Research

P1476

Oncogene pathway activation in mammary tumors dictates FDG-PET uptake

@en

P2093

Abass Alavi

http://www.w3.org/2001/XMLSchema#string

Chien-Chung Chen

http://www.w3.org/2001/XMLSchema#string

Eric Blankemeyer

http://www.w3.org/2001/XMLSchema#string

George K Belka

http://www.w3.org/2001/XMLSchema#string

James V Alvarez

http://www.w3.org/2001/XMLSchema#string

Joel S Karp

http://www.w3.org/2001/XMLSchema#string

Lewis A Chodosh

http://www.w3.org/2001/XMLSchema#string

Tien-Chi Pan

http://www.w3.org/2001/XMLSchema#string

P2860

[18F]FDG uptake and PCNA, Glut-1, and Hexokinase-II expressions in cancers and inflammatory lesions of the lung

Understanding the Warburg effect: the metabolic requirements of cell proliferation

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Comparison of triple-negative and estrogen receptor-positive/progesterone receptor-positive/HER2-negative breast carcinoma using quantitative fluorine-18 fluorodeoxyglucose/positron emission tomography imaging parameters: a potentially useful method

Cancer cell metabolism: Warburg and beyond

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

Genes that mediate breast cancer metastasis to lung

c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations.

Glucose metabolism of breast cancer assessed by 18F-FDG PET: histologic and immunohistochemical tissue analysis.

Oncogenic alterations of metabolism.

P304

7583-7598

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-14-1235

http://www.w3.org/2001/XMLSchema#string

P407

P433

24

http://www.w3.org/2001/XMLSchema#string

P478

74

http://www.w3.org/2001/XMLSchema#string

P577

2014-09-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25239452

http://www.w3.org/2001/XMLSchema#string

P932

4342047

http://www.w3.org/2001/XMLSchema#string